www.nnecos.org/concord ONS Accreditation Statement This continuing - - PowerPoint PPT Presentation

nnecos org concord ons accreditation statement
SMART_READER_LITE
LIVE PREVIEW

www.nnecos.org/concord ONS Accreditation Statement This continuing - - PowerPoint PPT Presentation

www.nnecos.org/concord ONS Accreditation Statement This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.


slide-1
SLIDE 1
slide-2
SLIDE 2
slide-3
SLIDE 3

www.nnecos.org/concord

slide-4
SLIDE 4
slide-5
SLIDE 5

ONS Accreditation Statement

This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

slide-6
SLIDE 6

Criteria for Successful Completion of Program Continuing Nursing Education (CNE)

  • Attendees seeking CNE must sign‐in and out of the conference
  • Attendees seeking CNE must submit a signed evaluation,

including attestation of sessions in which they participated before leaving the conference.

  • Certificates will be emailed to participants after the conference.

“This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.”

slide-7
SLIDE 7

Planning Committee Disclosures

Planning committee members with an * next to their name have no financial relationships to disclose.

  • Lori Aubrey*
  • Brenda Clements*
  • Emma Dann ‐ stock, Amgen & Gilead, 2008‐

present

  • Charlene Forcier*
  • Colette Horgan*
  • Amy Litterini ‐ employment & stock, Novo

Nordisk, spouse, 2005‐present

  • Matthew Marston*
  • Kathleen McBeth*
  • Elizabeth McGrath*
  • Nicole Messier ‐ payment for lectures, Teva &

Pfizer, 5/10/16, 11/30/16

  • Katie Michaud*
  • Rob Mills*
  • Michelle Pierce*
  • Maureen Stannard*
  • Amy Stansfield*
slide-8
SLIDE 8

Faculty Disclosures

Faculty members with an * next to their name have no financial relationships to disclose. Anna Schaal* Christine Howard* Danielle Fogg* Elizabeth Kimtis* Elizabeth McGrath* Emma Dann ‐ stock, Amgen & Gilead, 2008‐present Havaleh Gagne* James VanKirk* Joshua Hickman* Karen D. Schilling* Lauren McAdam* Linda Gascoyne* Lynsey Teulings* Mary Ellis ‐ Payment for lectures, including services

  • n speakers’ bureaus, Novartis, 2012‐present

Melissa Davis* Michaela Rowland* Nicolas LaPlante* Nicole Messier* ‐ payment for lectures, Teva &

Pfizer, 5/10/16, 11/30/16

Rob Mills* Shelagh Foster* Tracey Weisberg*

slide-9
SLIDE 9

PROGRAM GOALS

  • INNOVATIONS TRACK: To enhance attendees' understanding of ways to

improve existing healthcare services and the patient experience (Innovations in Cancer Care), resulting in an intent to change practice related to increased

  • pportunity for interdisciplinary collaboration and communication in the care
  • f the cancer patient.
  • OCN REVIEW TRACK: To enhance attendees' understanding of essential

knowledge required of an oncology certified nurse,

slide-10
SLIDE 10

Evaluation

We value your input! Please provide us with your feedback by completing the program evaluation. By completing the evaluation and submitting the answer sheet in collection boxes located at the registration desk, you will also document your attendance and be eligible to receive CE credits. Please note that evaluations and requests for credit must be submitted within 30 days after the meeting in order to be processed for educational credit.

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

REGISTER BY TUESDAY, MARCH 28TH! NHCANCERPLAN.ORG